Cargando…
Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis
INTRODUCTION: The coronavirus disease-2019 (COVID-19) has emerged as a novel infection which has spread rapidly across the globe and currently presents a grave threat to the health of the cancer patient. OBJECTIVE: The aim of this meta-analysis was to evaluate the proportion of hematological cancer...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673822/ https://www.ncbi.nlm.nih.gov/pubmed/34931178 http://dx.doi.org/10.1016/j.htct.2021.09.020 |
_version_ | 1784615522927640576 |
---|---|
author | Jafari, Mohammadali Dastgheib, Seyed Alireza Ferdosian, Farzad Mirjalili, Hamid Aarafi, Hossein Noorishadkam, Mahmood Mazaheri, Mahta Neamatzadeh, Hossein |
author_facet | Jafari, Mohammadali Dastgheib, Seyed Alireza Ferdosian, Farzad Mirjalili, Hamid Aarafi, Hossein Noorishadkam, Mahmood Mazaheri, Mahta Neamatzadeh, Hossein |
author_sort | Jafari, Mohammadali |
collection | PubMed |
description | INTRODUCTION: The coronavirus disease-2019 (COVID-19) has emerged as a novel infection which has spread rapidly across the globe and currently presents a grave threat to the health of the cancer patient. OBJECTIVE: The aim of this meta-analysis was to evaluate the proportion of hematological cancer patients with the SARS-CoV-2 infection during the COVID-19 pandemic. METHOD: A comprehensive literature review was performed on PubMed, Web of Science, Scopus, EKB SciELO, SID, CNKI and Wanfang databases to retrieve all relevant publications up to January 31, 2021. Observational studies, consecutive case-series and case-control studies were included. The proportion for hematological cancer patients with COVID-19 was estimated using the odds ratios (ORs) and 95% confidence interval (95% CIs). RESULTS: Fourteen studies with a total of 3,770 infected cancer patients and 685 hematological cancer cases with COVID-19 were selected. Combined data revealed that the overall proportion of hematological cancer patients with COVID-19 was 16.5% (95% CI 0.130 - 0.208, p ≤ 0.001). The stratified analysis by ethnicity showed that the proportion was 18.8% and 12.4% in Caucasian and Asian hematological cancer patients with COVID-19, respectively. Moreover, subgroup analysis by country of origin showed that its proportion was the highest in the United Kingdom (22.5%), followed by France (17.1%) and China (8.2%). CONCLUSION: This meta-analysis result indicated that the proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic was 16.5%. Further larger sample sizes and multicenter studies among different ethnic groups are necessary to get a better assessment of the proportion. |
format | Online Article Text |
id | pubmed-8673822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Sociedade Brasileira de Hematologia e Hemoterapia |
record_format | MEDLINE/PubMed |
spelling | pubmed-86738222021-12-16 Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis Jafari, Mohammadali Dastgheib, Seyed Alireza Ferdosian, Farzad Mirjalili, Hamid Aarafi, Hossein Noorishadkam, Mahmood Mazaheri, Mahta Neamatzadeh, Hossein Hematol Transfus Cell Ther Review Article INTRODUCTION: The coronavirus disease-2019 (COVID-19) has emerged as a novel infection which has spread rapidly across the globe and currently presents a grave threat to the health of the cancer patient. OBJECTIVE: The aim of this meta-analysis was to evaluate the proportion of hematological cancer patients with the SARS-CoV-2 infection during the COVID-19 pandemic. METHOD: A comprehensive literature review was performed on PubMed, Web of Science, Scopus, EKB SciELO, SID, CNKI and Wanfang databases to retrieve all relevant publications up to January 31, 2021. Observational studies, consecutive case-series and case-control studies were included. The proportion for hematological cancer patients with COVID-19 was estimated using the odds ratios (ORs) and 95% confidence interval (95% CIs). RESULTS: Fourteen studies with a total of 3,770 infected cancer patients and 685 hematological cancer cases with COVID-19 were selected. Combined data revealed that the overall proportion of hematological cancer patients with COVID-19 was 16.5% (95% CI 0.130 - 0.208, p ≤ 0.001). The stratified analysis by ethnicity showed that the proportion was 18.8% and 12.4% in Caucasian and Asian hematological cancer patients with COVID-19, respectively. Moreover, subgroup analysis by country of origin showed that its proportion was the highest in the United Kingdom (22.5%), followed by France (17.1%) and China (8.2%). CONCLUSION: This meta-analysis result indicated that the proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic was 16.5%. Further larger sample sizes and multicenter studies among different ethnic groups are necessary to get a better assessment of the proportion. Sociedade Brasileira de Hematologia e Hemoterapia 2022 2021-12-15 /pmc/articles/PMC8673822/ /pubmed/34931178 http://dx.doi.org/10.1016/j.htct.2021.09.020 Text en © 2021 Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Jafari, Mohammadali Dastgheib, Seyed Alireza Ferdosian, Farzad Mirjalili, Hamid Aarafi, Hossein Noorishadkam, Mahmood Mazaheri, Mahta Neamatzadeh, Hossein Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis |
title | Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis |
title_full | Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis |
title_fullStr | Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis |
title_full_unstemmed | Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis |
title_short | Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis |
title_sort | proportion of hematological cancer patients with sars-cov-2 infection during the covid-19 pandemic: a systematic review and meta-analysis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673822/ https://www.ncbi.nlm.nih.gov/pubmed/34931178 http://dx.doi.org/10.1016/j.htct.2021.09.020 |
work_keys_str_mv | AT jafarimohammadali proportionofhematologicalcancerpatientswithsarscov2infectionduringthecovid19pandemicasystematicreviewandmetaanalysis AT dastgheibseyedalireza proportionofhematologicalcancerpatientswithsarscov2infectionduringthecovid19pandemicasystematicreviewandmetaanalysis AT ferdosianfarzad proportionofhematologicalcancerpatientswithsarscov2infectionduringthecovid19pandemicasystematicreviewandmetaanalysis AT mirjalilihamid proportionofhematologicalcancerpatientswithsarscov2infectionduringthecovid19pandemicasystematicreviewandmetaanalysis AT aarafihossein proportionofhematologicalcancerpatientswithsarscov2infectionduringthecovid19pandemicasystematicreviewandmetaanalysis AT noorishadkammahmood proportionofhematologicalcancerpatientswithsarscov2infectionduringthecovid19pandemicasystematicreviewandmetaanalysis AT mazaherimahta proportionofhematologicalcancerpatientswithsarscov2infectionduringthecovid19pandemicasystematicreviewandmetaanalysis AT neamatzadehhossein proportionofhematologicalcancerpatientswithsarscov2infectionduringthecovid19pandemicasystematicreviewandmetaanalysis |